Brufen Rapidcaps 400 mg × 30 softgels

Brufen Rapidcaps 400 mg × 30 softgels

The drug contains the drug ibuprofen, which belongs to the non-steroidal anti-inflammatory drugs (NSAIDs). It works by reducing pain and fever. It is used in adults and adolescents with a body weight of 40 kg or more (aged 12 years and older) for the short-term symptomatic treatment of mild to moderate pain such as headache, toothache, menstrual pain and fever.

💊 Use

Dosing and dosage schedules
Adults and adolescents with a body weight of 40 kg or more (aged 12 years and older):
Recommended single dose: 400 mg, no more than 3 times a day if needed.
The interval between doses should be at least 6 hours.
The lowest effective dose should be used for the shortest time needed to control symptoms.
The maximum daily dose of 1200 mg is not to be exceeded within 24 hours.

You should contact your doctor if:
→ In adults, pain lasts longer than 4 days or fever lasts longer than 3 days or symptoms worsen,
→ in adolescents, the pain or fever lasts longer than 3 days or the symptoms get worse.

Method of use
The soft capsules are swallowed whole (they must not be bitten) and washed down with a glass of water.
Patients with a sensitive stomach are advised to take the capsules with food.

🍃 Composition

The active substance is ibuprofen. One capsule contains 400 mg of ibuprofen. - Other ingredients are: Core: Macrogol 600, potassium hydroxide (E 525), purified water. The capsule: gelatine (E 441), partially dehydrated sorbitol solution (E 420) and purified water.

⚠️️ Warning

The drug is contraindicated in the 3rd trimester.
The drug should not be given during the 1st and 2nd trimesters of pregnancy unless clearly necessary (if it must be used, the dose should be as low as possible and the duration of treatment as short as possible). The drug can usually be used in the breastfeeding period for short-term treatment at recommended doses for mild or moderate pain and fever.
Cyclooxygenase inhibitors may cause impaired fertility in women, due to an effect on ovulation (reversible, resolves after treatment is stopped).
The drug should not be used in adolescents with a body weight of less than 40 kg or children under 12 years of age.
Elderly patients should be monitored for the occurrence of gastrointestinal bleeding.
The drug is contraindicated in patients with severe hepatic impairment, severe renal impairment, or severe heart failure (NYHA Class IV). Prolonged use of higher than recommended doses or overdose may lead to renal tubular acidosis and hypokalaemia.
The drug should be discontinued at the first appearance of manifestations and symptoms of severe skin reactions.
If the drug is given during chickenpox, monitoring for infection is recommended.
Adequate fluid intake should be ensured while taking the drug.
In patients with risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) need careful consideration before starting long-term treatment, especially with high doses of ibuprofen.
Simultaneous consumption of the drug with alcohol should be avoided.
The drug may cause a photosensitive reaction - sensitivity to light (frequency of occurrence unknown).
The drug has no or negligible effect on the ability to drive and operate machinery.
Patients who experience dizziness, vertigo, visual disturbances, or other central nervous system disturbances while taking ibuprofen should not drive or operate machinery.
The drug contains sorbitol.